Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01139697
Other study ID # cortest-chf-1
Secondary ID
Status Completed
Phase N/A
First received May 20, 2010
Last updated May 15, 2012
Start date August 2010

Study information

Verified date May 2012
Source Meir Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine whether hair cortisol and testosterone levels correlate with heart failure status in patient with chronic congestive heart failure.


Description:

Progression of chronic congestive heart failure (CHF) is associated with abnormal secretion of several hormones including glucocorticoids and testosterone.

A single study of patients with chronic heart failure has demonstrated that higher serum levels of cortisol are independent predictors of increased mortality risk. However, this study included patients with heart failure who were admitted to the hospital due to other causes and it might be speculated that the single serum cortisol measurement taken may have been influenced by the acute illness or by the emotional stress associated with the admission itself.

Currently, there are several modalities for measuring cortisol levels including serum, urinary and salivary techniques. However, all these methods represent indicators of acute cortisol secretion and do not reflect accumulation of the hormone over time. Recently there has been a growing interest in measuring hair cortisol level. Hair grows approximately 1 centimeter per month and therefore hair analysis accurately reflects long-term endogenous production of cortisol. This provides for the first time a reliable mode for the measurement of the accumulation of cortisol over time. We have recently demonstrated higher hair cortisol levels in patients with acute myocardial infarction compared with controls (the manuscript has been submitted for publication). Regarding testosterone, several studies have recently demonstrated lower free serum testosterone levels in patients with heart failure compared with controls. Furthermore, Serum testosterone levels were inversely correlated with heart failure status.

The longitudinal assessment of cortisol and testosterone levels over time using the hair technique may be superior to a single random serum sample for the assessment of chronic heart failure status and prognosis.

If indeed, hair cortisol and testosterone levels would correlate with heart failure status, they may be used as a quantitative mode for clinical follow-up of CHF patients (similar to the role of HbA1C in the follow-up of diabetic patients). However this hypothesis has not yet been evaluated


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Males

- Age >18

- Left ventricular (LV) systolic function (EF<45 per echocardiography)

Exclusion Criteria:

- Any corticosteroid treatment in the last 6 months

- Any treatment with testosterone in the last 6 months

- Diagnosis or Cushing's or Addison's disease

- Any hospital admission within 3 months prior to enrollment

- Inability to sign inform consent

- Patients with moderate or severe aortic stenosis

- Inability to provide 3 cm hair sample from vertex posterior.

- Dyed hair

- Morbid obesity (BMI>35)

- Any symptomatic chronic lung disease

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Intervention

Other:
Hair sampling
Hair sampling for the measurement of cortisol and testosterone

Locations

Country Name City State
Israel Meir Medical Center Kfar Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (6)

Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007 Sep 22;370(9592):1089-100. Review. Erratum in: Lancet. 2007 Dec 1;370(9602):1828. — View Citation

Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation. 2007 Apr 3;115(13):1754-61. Epub 2007 Mar 19. — View Citation

Güder G, Frantz S, Bauersachs J, Allolio B, Ertl G, Angermann CE, Störk S. Low circulating androgens and mortality risk in heart failure. Heart. 2010 Apr;96(7):504-9. doi: 10.1136/hrt.2009.181065. Epub 2009 Oct 28. — View Citation

Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail. 2009 Jun;15(5):442-50. doi: 10.1016/j.cardfail.2008.12.011. Epub 2009 Feb 10. — View Citation

Sauvé B, Koren G, Walsh G, Tokmakejian S, Van Uum SH. Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med. 2007;30(5):E183-91. — View Citation

Van Uum SH, Sauvé B, Fraser LA, Morley-Forster P, Paul TL, Koren G. Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress. 2008 Nov;11(6):483-8. doi: 10.1080/10253890801887388. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of hair cortisol and testosterone with heart failure status Ccorrelation of hair cortisol and testosterone with clinical and laboratory parameters that their correlation with heart failure status is well established including:
Ejection fraction as assessed by echo-doppler.
Physical capacity as assessed by stress test.
Serum levels of hs-CRP, NT-proBNP. 4)1 year mortality
5)hospital admissions after 6 and 12 months
One year No
Secondary Mortality The association of hair cortisol and testosterone with mortality 6 and 12 months No
Secondary Hospital adMissions The correlation of hair cortisol and testosterone with hospital admission 6 and 12 months No
See also
  Status Clinical Trial Phase
Completed NCT02026102 - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs) N/A
Active, not recruiting NCT00949676 - DECIDE-HF: Heart Rate Variability in Heart Failure Patients N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT05230732 - Neuromodulation of Inflammation and Endothelial Function N/A
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Completed NCT02223403 - Effect of Nitrate-rich Beetroot Juice on Exercise Performance in Heart Failure Patients N/A
Completed NCT02946853 - Junctional AV Ablation in CRT-D: JAVA-CRT N/A
Completed NCT00833352 - Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Enrolling by invitation NCT03984591 - A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure Phase 4
Completed NCT02156583 - Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
Recruiting NCT01566344 - Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes N/A
Withdrawn NCT01127334 - Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device N/A
Completed NCT03534297 - Study of Dapansutrile Capsules in Heart Failure Phase 1
Completed NCT01765400 - Platelet Inhibition in Patients With Systolic Heart Failure Phase 4
Completed NCT01814319 - Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure Phase 2
Recruiting NCT02637167 - GutHeart: Targeting Gut Microbiota to Treat Heart Failure Phase 2
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT02084992 - A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure N/A
Completed NCT04937790 - Effects of Postural Balance Exercises in Patients With Heart Failure N/A